Quipt Home Medical (QIPT) director’s shares cashed out and options cancelled in deal

Rhea-AI Filing Summary

Quipt Home Medical Corp. director Kevin A. Carter disposed of his remaining equity position in connection with the company’s acquisition. On March 16, 2026, all 201,160 of his Common Shares were transferred under a plan of arrangement for a cash payment of US$3.65 per share. In addition, 5,625 stock options with a US$6.27 exercise price were surrendered to the issuer and cancelled with no cash consideration, consistent with the arrangement terms that options priced at or above US$3.65 receive no payment. Following these transactions, Carter no longer holds Quipt common shares or related options.

Insights

M&A and insider-transactions analyst

Director’s Form 4 reflects merger cash-out and option cancellation, not open-market selling.

The transactions show Kevin A. Carter, a director of Quipt Home Medical Corp., disposing of 201,160 Common Shares at US$3.65 per share under a court-supervised plan of arrangement. This is a compulsory deal-driven transaction, not a discretionary market sale.

Footnotes explain that all issued and outstanding shares were acquired by two purchasers at US$3.65, while options with exercise prices at or above that level, including Carter’s 5,625 options at US$6.27, were cancelled without consideration. As a result, Carter’s reported ownership falls to zero, consistent with the company being acquired and taken private.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carter Kevin A.

(Last) (First) (Middle)

C/O QUIPT HOME MEDICAL CORP.

1019 TOWN DRIVE

(Street)

WILDER KY 41076

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Quipt Home Medical Corp. [ QIPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	03/16/2026(1)		D		201,160(2)	D	$3.65	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$6.27	03/16/2026		D			5,625	(3)	(3)	Common Shares	5,625	(3)	0	D

Explanation of Responses:

1. On March 16, 2026, 1567208 B.C. LTD, a company existing under the laws of British Columbia ("B.C. Purchaser"), and REM Aggregator, LLC, a Delaware limited liability company (individually, "REM Aggregator", and collectively with B.C. Purchaser ("Purchaser" or "Purchasers") acquired all of the issued and outstanding common shares (the "Shares") of Issuer under a plan of arrangement (the "Arrangement Agreement") pursuant to the Business Corporations Act (British Columbia) (the "BCBCA"). At the Effective Time (the "Effective Time") of the Arrangement Agreement each Share, other than any Shares held by shareholders who properly exercised dissent rights under the BCBCA ("Dissenting Shareholders"), were deemed to be transferred to Purchaser in consideration for the right to receive a cash payment from the Purchaser in the amount equal to US$3.65, without interest.

2. Pursuant to a forfeiture agreement entered into by Issuer and Mr. Carter, 76,732 restricted share units ("RSUs") were forfeited immediately prior to the Effective Time and terminated in connection with the Arrangement Agreement. Each RSU is the economic equivalent of one Share.

3. Pursuant to the terms of the Arrangement Agreement, immediately following the Effective Time, each option exercisable to acquire one or more Shares from the Issuer (an "Option"), outstanding immediately prior to the Effective Time (whether vested or unvested) were deemed to be unconditionally vested and exercisable and will, without any further action by or on behalf of a holder of the Option, deemed to be surrendered and transferred by such holder to the Issuer in consideration for the right to receive a cash payment from the Issuer in an amount equal to the excess, if any, of US$3.65 over the exercise price of such option, less any amounts the Issuer is required to withhold for taxes, without interest. Any option for which the exercise price is equal to or greater than US$3.65 will be cancelled for no consideration.

	/s/ Kevin A. Carter	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Quipt Home Medical (QIPT) director Kevin A. Carter report in this Form 4?

He reported the disposition of all 201,160 Common Shares and 5,625 stock options on March 16, 2026. The equity was removed as part of a plan of arrangement tied to Quipt Home Medical’s acquisition for cash consideration of US$3.65 per share.

At what price were Kevin A. Carter’s Quipt Home Medical (QIPT) shares cashed out?

Each Common Share was transferred for US$3.65 in cash under a plan of arrangement. This price applied to all issued and outstanding shares other than those held by properly dissenting shareholders, according to the transaction footnotes describing the acquisition structure.

What happened to Kevin A. Carter’s Quipt Home Medical (QIPT) stock options?

He surrendered 5,625 stock options with a US$6.27 exercise price, which were cancelled with no payment. The arrangement terms state options with exercise prices equal to or above US$3.65 are cancelled for no consideration immediately after the effective time of the transaction.

Does Kevin A. Carter still hold Quipt Home Medical (QIPT) shares after this transaction?

No. The Form 4 shows total shares following the transactions as zero for both Common Shares and the reported options. All of his reported equity interests were eliminated in connection with the acquisition and related plan of arrangement described in the filing footnotes.

What corporate event triggered the Quipt Home Medical (QIPT) insider disposition reported here?

A plan of arrangement under the Business Corporations Act (British Columbia) led to all issued and outstanding common shares being acquired for US$3.65 per share. This court-supervised transaction caused the automatic transfer of shares and treatment of options and RSUs described in the footnotes.